J.P. Morgan Roundtable: Making Deals And Managing Alliances As Technologies Advance
Executive Summary
Part 2: Scrip spoke with companies working on cell and gene therapies and novel neurology approaches during the J.P. Morgan Healthcare Conference about the dos and don'ts of deal-making as they advance innovative programs into the clinic and beyond.